Concepedia
Statistics
Publications
6
Citations
349
H-Index
Active since
1997
Affiliations
Eutropics Pharmaceuticals (United States)(Current)
The University of Texas MD Anderson Cancer Center
Translational Genomics Research Institute
Ryan Lena is an author at Eutropics Pharmaceuticals (United States) specializing in pharmacology, medicine, and chemotherapy.
Publications per year
1997–2014
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
James M. Bogenberger, Steven M. Kornblau, William E. Pierceall et al. · Leukemia · 2014 · 197 citations · Full text
Medicine, Oncology, Pharmacology +13
Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker
David J. Richard, Ryan Lena, Thomas D. Bannister et al. · Bioorganic & Medicinal Chemistry · 2013 · 55 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response
Timothy G. Whitsett, Ian T. Mathews, Michael H. Cardone et al. · Molecular Cancer Research · 2014 · 43 citations · Full text
Medicine, Oncology, Pharmacology +17
BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia
William E. Pierceall, Steven M. Kornblau, Nicole E. Carlson et al. · Molecular Cancer Therapeutics · 2013 · 32 citations · Full text
Medicine, Oncology, Pharmacology +15
Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia
William E. Pierceall, Ryan Lena, Bruno C. Medeiros et al. · Leukemia Research · 2014 · 12 citations · Full text
Medicine, Hematology, Oncology +12
1–5 of 6